Discontinuation report ATROVENT NASAL SPRAY

Last updated on 2018-10-17 History
Report ID 64493
Drug Identification Number 02163705
Brand name ATROVENT NASAL SPRAY
Common or Proper name ATROVENT Nasal Spray 0.03%, 345 doses - 21 mcg
Company Name SANOFI-AVENTIS CANADA INC
Active Ingredient(s) IPRATROPIUM BROMIDE
Strength(s) 21MCG
Dosage form(s) SOLUTION
Route of administration NASAL
Packaging size 30ml
ATC code R01AX
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-10-04
Actual discontinuation date 2018-10-04
Remaining supply date 2018-10-04
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-10-17 French Compare
v3 2018-10-17 English Compare
v2 2018-10-17 French Compare
v1 2018-10-17 English Compare